Company intelligence / Profile preview

HeartFlow

Mountain View, California, United Statesheartflow.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

HeartFlow’s AI-powered platform is commercially available in the US, UK, Japan, and Canada. It provides non-invasive 3D modeling of coronary arteries from CCTA scans to assess anatomy and physiology for coronary artery disease diagnosis. The technology has been validated in over 500 peer-reviewed publications and adopted by more than 750 hospitals worldwide[5][7]. Clinical studies have demonstrated improved accuracy in CAD diagnosis compared to traditional methods[2][5].

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy (AI-enabled diagnostic imaging)
Industry: Medical Imaging

Beyond the preview

Go deeper on HeartFlow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HeartFlow.

Explore the full profile